Target intelligence / Profile preview

RNA, U6 small nuclear 477, pseudogene (RNU6-477P)

Target
RNU6-477P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6 small nuclear 477, pseudogene (RNU6-477P) is classified as a pseudogene that is related in sequence to the U6 small nuclear RNA, which itself is involved in the spliceosome and pre-mRNA splicing in eukaryotic cells. As a pseudogene, RNU6-477P is not known to encode a functional product and is not considered a therapeutic target. There is no evidence linking this pseudogene to disease processes, drug interactions, or biomarker roles[1][6].

Other names
RNU6-477P

Beyond the preview

Go deeper on RNA, U6 small nuclear 477, pseudogene (RNU6-477P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 477, pseudogene (RNU6-477P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call